Literature DB >> 6127458

Influence of delta infection on severity of hepatitis B.

A Smedile, P Farci, G Verme, F Caredda, A Cargnel, N Caporaso, P Dentico, C Trepo, P Opolon, A Gimson, D Vergani, R Williams, M Rizzetto.   

Abstract

The prevalence of serum markers of primary delta infection was determined in 532 patients with acute benign hepatitis B seen in Italy, and in 111 patients with fulminant hepatitis B seen in Italy, France and England. Patients with fulminant hepatitis had significantly higher prevalence of delta markers (43/111, 39%) than did those with benign hepatitis (101/532, 19%). In 25 of the 43 patients with delta-positive fulminant hepatitis, serum markers indicated a primary hepatitis B infection while in the remaining 18, IgM antibody to hepatitis B core antigen was absent, indicating that hepatitis B preceded superinfection with the delta agent. The increased morbidity of HBsAg hepatitis with delta infection may result from the cumulative simultaneous exposure to hepatitis B virus and delta, or from superinfection of HBsAg carriers with delta.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127458     DOI: 10.1016/s0140-6736(82)90156-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  76 in total

Review 1.  Fulminant hepatic failure. Clinical features, etiology, epidemiology, and current management.

Authors:  L Capocaccia; M Angelico
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

Review 2.  Hepatitis delta virus: A fascinating and neglected pathogen.

Authors:  Celso Cunha; João Paulo Tavanez; Severin Gudima
Journal:  World J Virol       Date:  2015-11-12

Review 3.  Blood transfusion and hepatitis: still a threat?

Authors:  H W Reesink; C L van der Poel
Journal:  Blut       Date:  1989-01

4.  Prevalence of hepatitis delta (delta) virus infection. A seroepidemiologic study.

Authors:  K M DeCock; B Jones; S Govindarajan; A G Redeker
Journal:  West J Med       Date:  1988-03

5.  Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.

Authors:  G Garcia; A Smedile; K F Bergmann; J L Gerin; P B Gregory; T C Merigan; W S Robinson
Journal:  West J Med       Date:  1990-07

Review 6.  Viral hepatitis.

Authors:  J Y Lau; G J Alexander; A Alberti
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

7.  Attempted treatment of fulminant viral hepatitis with human fibroblast interferon.

Authors:  F Milazzo; M Galli; P G Fassio; A Cargnel; A Pugliese; P A Tovo; G M Vigevani; R Esposito; A Lazzarin; F Caredda
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

Review 8.  Hepatitis D and hepatocellular carcinoma.

Authors:  Zaigham Abbas; Minaam Abbas; Sarim Abbas; Lubna Shazi
Journal:  World J Hepatol       Date:  2015-04-18

9.  Delta infection among patients with chronic hepatitis B in the Stockholm region.

Authors:  G Lindh; O Weiland; B G Hansson; A Svedmyr
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

10.  Permanent HBsAg clearance in chronic hepatitis B viral infection following acute delta superinfection.

Authors:  K P Chin; S Govindarajan; A G Redeker
Journal:  Dig Dis Sci       Date:  1988-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.